Trial Outcomes & Findings for Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment (NCT NCT00699660)

NCT ID: NCT00699660

Last Updated: 2018-08-16

Results Overview

total completeness of diagnostic assessment score, range from 0 to 100% and completeness of functional assessment

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

406 participants

Primary outcome timeframe

Post-exam, same day

Results posted on

2018-08-16

Participant Flow

Participant milestones

Participant milestones
Measure
Arm 1
PTSD interview using CAPS and WHODAS Clinician Assessment of PTSD Symptoms (CAPS): CAPS/WHODAS structured clinical PTSD interview
Arm 2
Usual PTSD interview, without CAPS or WHODAS Nonstructured Interview: Usual PTSD clinical PTSD interview, not CAPS or SCID
Overall Study
STARTED
190
216
Overall Study
COMPLETED
176
208
Overall Study
NOT COMPLETED
14
8

Reasons for withdrawal

Reasons for withdrawal
Measure
Arm 1
PTSD interview using CAPS and WHODAS Clinician Assessment of PTSD Symptoms (CAPS): CAPS/WHODAS structured clinical PTSD interview
Arm 2
Usual PTSD interview, without CAPS or WHODAS Nonstructured Interview: Usual PTSD clinical PTSD interview, not CAPS or SCID
Overall Study
Lost to Follow-up
4
2
Overall Study
missing reports and recording failures
10
6

Baseline Characteristics

Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Arm 1
n=176 Participants
PTSD interview using CAPS and WHODAS Clinician Assessment of PTSD Symptoms (CAPS): CAPS/WHODAS structured clinical PTSD interview
Arm 2
n=208 Participants
Usual PTSD interview, without CAPS or WHODAS Nonstructured Interview: Usual PTSD clinical PTSD interview, not CAPS or SCID
Total
n=384 Participants
Total of all reporting groups
Age, Continuous
60 years
n=5 Participants
59 years
n=7 Participants
59 years
n=5 Participants
Sex: Female, Male
Female
6 Participants
n=5 Participants
13 Participants
n=7 Participants
19 Participants
n=5 Participants
Sex: Female, Male
Male
170 Participants
n=5 Participants
195 Participants
n=7 Participants
365 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
44 Participants
n=5 Participants
56 Participants
n=7 Participants
100 Participants
n=5 Participants
Race (NIH/OMB)
White
103 Participants
n=5 Participants
124 Participants
n=7 Participants
227 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
29 Participants
n=5 Participants
28 Participants
n=7 Participants
57 Participants
n=5 Participants
Marital Status
Married
108 participants
n=5 Participants
130 participants
n=7 Participants
238 participants
n=5 Participants
Marital Status
Single
28 participants
n=5 Participants
35 participants
n=7 Participants
63 participants
n=5 Participants
Marital Status
Separated
32 participants
n=5 Participants
37 participants
n=7 Participants
69 participants
n=5 Participants
Marital Status
Other/Missing
8 participants
n=5 Participants
6 participants
n=7 Participants
14 participants
n=5 Participants

PRIMARY outcome

Timeframe: Post-exam, same day

total completeness of diagnostic assessment score, range from 0 to 100% and completeness of functional assessment

Outcome measures

Outcome measures
Measure
Arm 1
n=176 Participants
PTSD interview using CAPS and WHODAS Clinician Assessment of PTSD Symptoms (CAPS): CAPS/WHODAS structured clinical PTSD interview
Arm 2
n=208 Participants
Usual PTSD interview, without CAPS or WHODAS Nonstructured Interview: Usual PTSD clinical PTSD interview, not CAPS or SCID
Completeness and Quality of PTSD Interview
completeness of diagnostic assessment
84.8 percentage of criteria PTSD assessment
Standard Deviation 17.3
29.8 percentage of criteria PTSD assessment
Standard Deviation 24.4
Completeness and Quality of PTSD Interview
completeness of functional assessment
76.2 percentage of criteria PTSD assessment
Standard Deviation 24.4
3.1 percentage of criteria PTSD assessment
Standard Deviation 7.5

SECONDARY outcome

Timeframe: Post-exam, same day

Number of participants who were unable to receive a conclusive clinician PTSD diagnosis for positive or negative PTSD symptoms (unable to determine clinician diagnosis).

Outcome measures

Outcome measures
Measure
Arm 1
n=176 Participants
PTSD interview using CAPS and WHODAS Clinician Assessment of PTSD Symptoms (CAPS): CAPS/WHODAS structured clinical PTSD interview
Arm 2
n=208 Participants
Usual PTSD interview, without CAPS or WHODAS Nonstructured Interview: Usual PTSD clinical PTSD interview, not CAPS or SCID
PTSD Diagnosis
Uanble to determine clinician PTSD+ diagnosis
49 participants
110 participants
PTSD Diagnosis
Unable to determine PTSD- diagnosis
14 participants
73 participants

SECONDARY outcome

Timeframe: post-exam, same day

Mean score on satisfaction survey rating scale from 1 to 5 (higher)

Outcome measures

Outcome measures
Measure
Arm 1
n=176 Participants
PTSD interview using CAPS and WHODAS Clinician Assessment of PTSD Symptoms (CAPS): CAPS/WHODAS structured clinical PTSD interview
Arm 2
n=208 Participants
Usual PTSD interview, without CAPS or WHODAS Nonstructured Interview: Usual PTSD clinical PTSD interview, not CAPS or SCID
Patient Satisfaction
4.69 units on a scale
Standard Deviation .44
4.74 units on a scale
Standard Deviation .38

SECONDARY outcome

Timeframe: same day

time spent administering the exam

Outcome measures

Outcome measures
Measure
Arm 1
n=176 Participants
PTSD interview using CAPS and WHODAS Clinician Assessment of PTSD Symptoms (CAPS): CAPS/WHODAS structured clinical PTSD interview
Arm 2
n=208 Participants
Usual PTSD interview, without CAPS or WHODAS Nonstructured Interview: Usual PTSD clinical PTSD interview, not CAPS or SCID
Resource Utilization
216.6 minutes
Standard Deviation 88.6
157.2 minutes
Standard Deviation 63.8

Adverse Events

Arm 1

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Arm 2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Theodore Speroff PhD

Veterans Affairs at TVHS

Phone: 615-636-9476

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place